Clinical Trial

Prevalence of Suicidal Risk in Psychiatric Settings

Study acronym: RSCP
Completed
View on ClinicalTrials.gov →
Summary
France is among the countries with one of the highest suicide rates in the world, far ahead of its neighboring nations \[Wasserman et al., 2012\]. Suicide represents the second leading cause of death among 15-24-year-olds, just after road accidents, and the leading cause of death among 25-34-year-olds. In this context, a better utilization of all components of the healthcare system seems highly desirable, particularly through greater involvement of community psychiatrists in suicide prevention strategies. Approximately 25% of individuals who die by suicide have consulted a psychiatrist in the month preceding their death \[Luoma et al., 2002\], yet few data are available on this topic, especially regarding consultations with community psychiatrists outside of hospital settings. Study objectives Main objective To assess the prevalence of suicidal risk during the 15 days preceding an outpatient psychiatric consultation in the Clermont-Ferrand area. Main secondary objectives * To describe the recruited population and potentially associated factors (age, sex, etc.). * To assess the psychological pain of these individuals over the same period when suicidal thoughts are strongest, or, if absent, when they feel at their worst. * To assess the self-esteem of these individuals over the same period when suicidal thoughts are strongest, or, if absent, when they feel at their worst.
Trial Details
NCT Number NCT07746193
Lead Sponsor University Hospital, Clermont-Ferrand
Conditions Psychiatric Disorder, Suicidal Crisis
Enrollment 262 participants
Start Date 2025-05-01
Primary Completion 2025-05-01 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-04